Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.70 +0.01 (+1.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Change in Receivables (2023 - 2026)

Updated

Milestone Pharmaceuticals (MIST) recorded Change in Receivables of $1.12 million in Q2 2026, down 30.5% from the prior quarter.

Analysis

Milestone Pharmaceuticals (MIST) Change in Receivables (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 1.37 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 333.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Milestone Pharmaceuticals 97.49 Mn -73.11 Mn - 1.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.12 Mn
Mar 31, 2026 1.61 Mn
Mar 31, 2023 1.00 Mn
API Access

Milestone Pharmaceuticals Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=MIST&period=max&api_key=YOUR_API_KEY